Armistice Capital, Llc

13F Holdings History for Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

Symbol: AUTL on Nasdaq
Investment type: Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
Latest Disclosed Ownership: 15.6M shares
Security Ownership: 5.86%

Shares, Excluding Options vs Price

Value, Excluding Options

Armistice Capital, LLC ownership in Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

2025-11-14 - Armistice Capital, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 15.6M shares of Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL). This represents 5.86% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Armistice Capital, LLC	5.86%		$25.4M	15.6M			$1.63	13G	9/30/2025	14 Nov 2025 18:38:59
Armistice Capital, LLC	4.99%		$2.1M	1.18M			$1.78	13G/A	6/30/2025	14 Aug 2025 20:46:30

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.8%	+0.18%	$25.4M	15.6M	+3,600,000	+30%	$1.63	Q3 2025
6/30/2025	1.04%	+0.09%	$27.4M	12M	+1,000,000	+9.09%	$2.28	Q2 2025
3/31/2025	0.46%	+0.07%	$17.1M	11M	+1,800,000		$1.55	Q1 2025
12/31/2024	0.5%	+0.13%	$21.6M	9.2M	+2,328,000	+33.9%	$2.35	Q4 2024
9/30/2024	0.65%	+0.06%	$24.9M	6.87M	+622,000	+9.95%	$3.63	Q3 2024
6/30/2024	0.57%	+0.15%	$21.8M	6.25M	+1,578,000	+33.8%	$3.48	Q2 2024
3/31/2024	0.79%	+0.07%	$29.8M	4.67M	+822,000	+21.4%	$6.38	Q1 2024
12/31/2023	0.34%	-0.3%	$24.8M	3.85M	-3,050,000	-44.2%	$6.44	Q4 2023
9/30/2023	0.25%	-0.01%	$16.1M	6.9M	-364,000	-5.01%	$2.33	Q3 2023
6/30/2023	0.25%	-0.08%	$17.3M	7.26M	-2,408,000	-24.9%	$2.38	Q2 2023
3/31/2023	0.26%	-0.01%	$17.8M	9.67M	-552,000	-5.4%	$1.84	Q1 2023
12/31/2022	0.34%	+0.34%	$19.4M	10.2M	+10,224,000	NEW	$1.90	Q4 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.